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ABSTRACT
Stress granules (SGs) are large cytoplasmic ribonu-
cleoprotein complexes that are assembled when
cells are exposed to stress. SGs promote the
survival of stressed cells by contributing to the
reprogramming of protein expression as well as by
blocking pro-apoptotic signaling cascades. These
cytoprotective effects implicated SGs in the resist-
ance of cancer cells to radiation and chemotherapy.
We have found that sodium selenite, a selenium
compound with chemotherapeutic potential, is a
potent inducer of SG assembly. Selenite-induced
SGs differ from canonical mammalian SGs in their
morphology, composition and mechanism of
assembly. Their assembly is induced primarily by
eIF4E-binding protein1 (4EBP1)-mediated inhibition
of translation initiation, which is reinforced by con-
current phosphorylation of eIF2a. Selenite-induced
SGs lack several classical SG components,
including proteins that contribute to pro-survival
functions of canonical SGs. Our results reveal a
new mechanism of mammalian SG assembly and
provide insights into how selenite cytotoxicity may
be exploited as an anti-neoplastic therapy.
INTRODUCTION
Stress-induced translational repression is a consequence of
reduced translation initiation. This is achieved by inhibit-
ing the assembly of eIF4F (i.e. eIF4E: eIF4G: eIF4A)
and 43S pre-initiation complexes (1). Assembly of eIF4F
complexes is inhibited by eIF4E-binding proteins (4EBPs)
that block interactions between eIF4E and eIF4G to
down-regulate 50-cap-dependent translation initiation.
Typically, dephosphorylation of 4EBPs by stress-induced
inactivation of the PI3K-mTOR (mammalian target of
rapamycin) pathway promotes 4EBP-mediated transla-
tional repression. Assembly of 43S complexes is inhibited
by stress-induced activation of PKR, PERK, GCN2 and
HRI, kinases that phosphorylate eIF2a, a component of
the eIF2-GTP-tRNA
Met ternary complex that is required
for 43S pre-initiation complex assembly. These comple-
mentary mechanisms are largely responsible for the
general translational repression observed in cells exposed
to adverse environmental conditions.
Non-translating messenger RNA (mRNAs) that accu-
mulate as a result of stress-induced translational repres-
sion are frequently compartmentalized into cytoplasmic
foci known as stress granules (SGs). SGs are large ribonu-
cleoprotein (RNP) complexes composed of abortive trans-
lation initiation complexes and an eclectic assortment of
RNA-binding proteins and signaling proteins involved in
various aspects of cellular metabolism (2). These include
tumor necrosis factor receptor-associated factor 2
(TRAF2), receptor for activated C kinase 1 (RACK1)
and plakophilin3, which are routed to SGs as a conse-
quence of interactions with core SG components (3–5).
Current evidence suggests that SGs, together with a
related RNA granule known as the processing (P-) body,
play important roles in determining the fate of mRNAs in
stressed cells. Some RNAs are stored in the granules,
others are degraded and still others are returned to the
cytoplasm for translation (6). SGs have also been
implicated in signaling cascades that determine whether
stressed cells live or die. Thus, the recruitment and
sequestration of TRAF2 and RACK1 were reported to
inhibit inﬂammatory signaling and stress-induced apop-
totic signaling (3,4), respectively. Furthermore, cells
impaired in the ability to assemble SGs invariably show
reduced survival upon exposure to environmental stress
(7–10). Thus, SGs are thought to promote cell survival
under stress conditions through modulation of various
aspects of cell metabolism.
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beneﬁcial to individual cells or unicellular organisms, this
may not be the case for multicellular organisms, in which
the proper execution of apoptosis is required for differen-
tiation and general survival. The cytoprotective functions
of SGs may also beneﬁt tumor cells by allowing the
survival of poorly vascularized tumor cells. Indeed,
several studies now implicate SGs in cancer biology.
Aside from the inhibition of apoptosis by sequestration
of signaling molecules as described above, SGs assembled
in hypoxic tumor cells have been shown to inhibit the
translation of angiogenic factors and promote resistance
to radiotherapy (11). In addition, SG assembly is induced
by bortezomib (commercially known as Velcade), a pro-
teasome inhibitor whose anti-tumor effects are inversely
correlated with SG assembly (12). It is therefore likely that
SGs promote resistance to radio- and chemotherapy in
cancer cells.
Selenium is an essential micronutrient that has both
chemopreventive and chemotherapeutic properties (13).
At nutritional levels ( 50nM), selenium is incorporated
into selenoproteins that function as anti-oxidants. At
supranutritional levels (>1mM), selenium acts as a
pro-oxidant through the activities of its metabolites,
which promote the production of reactive oxygen species
(ROS).Importantly,highdosesofseleniumcompoundsare
selectively toxic to cancer cells. Although the mechanism of
this tumor cell-speciﬁc cytotoxicity is not fully understood,
cancercellsmaybeparticularlysusceptibletoROSinduced
by selenium metabolism (14). A recent study also
demonstratedthatcancercellsspeciﬁcallydisplayincreased
uptake of selenium compounds (15). Interestingly, the efﬁ-
ciency of uptake was positively correlated with the expres-
sion level of multi-drug resistance (MDR) proteins, a
hallmark of chemoresistance and tumor malignancy;
increased expression of MDR proteins leads to increased
uptake of selenium compounds and increased toxicity
(15). These results suggest that selenium compounds could
be used to speciﬁcally target tumor cells that cannot be
eliminated by conventional chemotherapy.
In addition to the induction of ROS, selenium
compounds trigger endoplasmic reticulum (ER) stress,
which results in phosphorylation of eIF2a (16,17). Since
eIF2a phosphorylation is the major trigger of SGs, we
tested the ability of selenium compounds to induce the
assembly of SGs. In this study, we focused on sodium
selenite, the most common dietary form of water-soluble
selenium compound which was also the most effective
anti-tumor compound (15). We found that selenite
potently inhibits translation and induces the ROS-
dependent assembly of SGs that lack the pro-survival
proteins found in typical SGs. Our results uncover a
novel aspect of selenite-induced cytotoxicity that is
relevant to the use of selenite as an anti-cancer drug.
MATERIALS AND METHODS
Reagents, antibodies and small interfering RNA
Sodium arsenite, sodium selenite, emetine, cycloheximide
and rapamycin were purchased from Sigma-Aldrich.
MnTMPyP (manganese (III) tetrakis (1-methyl-4-pyridyl)
porphyrin) was obtained from Enzo Life Sciences. The
following antibodies were used for western blotting and
immunoﬂuorescence: anti-eIF3b (goat polyclonal, N-20),
eIF3e (goat polyclonal, C-20), eIF4E (mouse monoclonal,
P-2), eIF4G1 (rabbit polyclonal, H-300), G3BP1 (mouse
monoclonal, TT-Y), FMR1 (mouse monoclonal, 148.1),
Hedls (mouse monoclonal, originally intended to react
with S6K1 (18), H-9), HDAC6 (rabbit polyclonal,
H-300), HuR (mouse monoclonal, 3A2), PABP (mouse
monoclonal, 10E10), RACK1 (mouse monoclonal, B-3)
and TIAR (goat polyclonal, C-18) from Santa Cruz
Biotechnology; anti-eIF4E-binding protein1 (4EBP1)
(rabbit polyclonal), phospho-4EBP1 (Thr37/46, rabbit
monoclonal), eIF4A1 (rabbit monoclonal), ribosomal S6
(mouse monoclonal), phospho-ribosomal S6 (rabbit poly-
clonal) and Rsk2 (rabbit monoclonal) from Cell Signaling
Technology; anti-b-actin (mouse monoclonal) from
Chemicon; anti-eIF5A (mouse monoclonal) from BD
Biosciences; anti-G3BP1 (rabbit polyclonal) from Bethyl;
anti-phospho-eIF2a (rabbit polyclonal) from Assay
Designs; anti-Ago2 (mouse monoclonal) from Wako
Bioproducts; anti-PCBP2 (mouse monoclonal) from
Abnova; anti-O-GlcNAc (mouse IgM, CTD110.6) from
Covance; anti-importin b1 (mouse monoclonal)
from Pierce; anti-small ribosomal S14 (rabbit polyclonal)
from Proteintech group. Anti-Rch1/importin a1 (mouse
monoclonal) antibody was kindly provided by Dr. Jun
Katahira (Osaka University). Secondary antibodies used
for immunoﬂuorescence (Cy2-, Cy3- and Cy5-conjugated)
and western blotting (horseradish peroxidase-conjugated)
were from Jackson Immunoresearch Laboratories.
Biotinylated oligo-dT18 probe was purchased from IDT.
Non-targeting, control small interfering RNA (siRNA)
(U0) was as described previously (19). siRNA targeting
human 4EBP1 was purchased from QIAGEN; the
target sequence was 50-TCGGAACTCACCTGTGAC
CAA-30.
Cell culture, drug treatment and transfections
Human osteosarcoma U2OS cells, human prostatic car-
cinoma DU145 cells, mouse embryonic ﬁbroblasts
(MEFs) with or without the S51A mutation of eIF2a
and TP53 /  MEFs with or without TSC2 deﬁciency
were maintained at 37 Ci naC O 2 incubator in
Dulbecco’s modiﬁed Eagle’s medium (Gibco) supple-
mented with 10% fetal bovine serum (Sigma) and 1%
penicillin/streptomycin. For SG induction, cells grown to
 70% conﬂuency were treated with arsenite (100mM, 1h)
or selenite (1mM, 2h) unless otherwise indicated. Emetine
and cycloheximide treatment was done as described pre-
viously (20). siRNA transfection was performed using
Lipofectamine 2000 (Invitrogen), basically according to
the manufacturer’s instructions. Brieﬂy, 20pmol of
siRNA and 1ml of Lipofectamine 2000, each diluted in
50ml of OPTI-MEM, were mixed and added to cells
plated at the density of 1.5 10
4 cells/well in a 24-well
plate. Cells were subjected to assays 72h after
transfection.
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Following drug treatment, cells were washed with phos-
phate buffered saline (PBS) and directly lysed in
Laemmli’s sample buffer supplemented with 100mM
dithiothreitol (DTT), boiled and stored at  20 C until
use. The samples were resolved using a gradient 4–20%
Tris–Glycine gel (Invitrogen), transferred to a nitrocellu-
lose membrane, which was probed with the indicated
primary antibodies (used at the dilution of 1:2000,
except for anti-b-actin antibody, which was used at the
dilution of 1:5000) using 5% normal horse serum diluted
in PBS (normal human serum/PBS) as a blocking reagent.
Following extensive washes, the membrane was incubated
with appropriate secondary antibodies (at the dilution of
1:5000), and antibody detection was performed using
SuperSignal West Pico Chemiluminescent Substrate
(Themo Scientiﬁc).
Metabolic labeling
Cells grown in six-well plates (1.5 10
5 cells/well) were
treated either with arsenite or selenite for 1h, followed
by 1h of labeling with 0.5mCi of C
14-lysine (American
Radiolabeled Chemicals, Inc.; ARC0459) and C
14-
leucine (Moravek Biochemicals, Inc.; MC175W) in the
presence or the absence of drugs. Afterwards, cells were
washed and harvested in PBS and split evenly into two
tubes. Perchloric acid precipitation was performed for one
of the pools to measure the amount of incorporated C
14-
labeled amino acids into proteins; the other pool was sus-
pended in 0.5M NaOH and the total protein amount was
measured by Bio-Rad Protein Assay kit.
m
7GTP-sepharose pulldown assay
Cells grown on 10-cm dishes were lysed in 0.5ml/dish of
lysis buffer (Tris–HCl pH7.4, 100mM NaCl, 1mM
ethylenediaminetetraacetic acid, 0.5% NP-40, supple-
mented with a protease inhibitor tablet (Roche) just
before use), and centrifuged for 15min at 13000rpm at
4 C. The supernatant containing 1mg of total protein was
transferred to a clean tube and incubated with prewashed
15ml suspension of m
7GTP-sepharose (GE Healthcare)
for 2h at 4 C with rotation. The beads were washed ex-
tensively with the lysis buffer and cap-bound materials
were eluted by boiling in 60mlo f2  Laemmli’s sample
buffer supplemented with 100mM DTT.
Immunoﬂuorescence and in situ hybridization
Immunoﬂuorescence was performed essentially as
described previously (19). Brieﬂy, cells were ﬁxed in par-
aformaldehyde, permeabilized with methanol at  20 C
and then blocked with normal human serum/PBS for at
least 30min. For staining of eIF5A, importin b1 and
HDAC6, permeabilization was performed by treating
cells with 0.2% Triton X-100 in PBS for 10min.
Subsequently, primary antibodies were added at the
dilution of 1:300, incubated for 1h at room temperature,
followed by incubation with secondary antibodies at the
dilution of 1:300. Eventually, cells were washed exten-
sively, stained with Hoechst to reveal nuclei and
mounted using Vinol mounting media. Wide-ﬁeld ﬂuores-
cence microscopy was performed using an Eclipse E800
microscope (Nikon) equipped with epiﬂuorescence optics
and digital camera (CCD-SPOT RT; Diagnostic
Instruments). Image acquisition was done with a 40  ob-
jective (PlanApo; Nikon). Acquired images were compiled
using Adobe Photoshop. Quantiﬁcation of the percentage
of SG-positive cells was done by counting the number of
cells with at least two discrete TIAR- and G3BP-positive
foci from >100 cells, from at least three independent ex-
periments. For in situ hybridization, cells were processed
as described previously (21), and hybridization was per-
formed using a biotinylated oligo-dT18 probe and in situ
hybridization buffer (Ambion) at 37 C. After extensive
washes with 0.5 saline-sodium citrate (SSC), probe was
revealed using Cy2-conjugated streptavidin (Jackson
Immunoresearch Laboratories), followed by
immunostaining of TIAR and G3BP. For the measure-
ment of SG size, the ‘Analyze particle’ tool of the
ImageJ software (NIH) was used.
Cell viability assay
Cell viability assay was performed essentially as described
previously (22). Brieﬂy, U2OS cells transfected either with
control or 4EBP1 siRNA were seeded into 48-well plates
(1 10
4 cells/well) 48h after transfection. After overnight
culture, cells were treated with arsenite (100mM for 2 or
4h) or selenite (either at 1mM for 1h, or at 10mM and
20mM for 24h) and cell viability was measured using
CellTiter-Glo (Promega) and Veritas Microplate
Luminometer (Turner Biosystems) following the manufac-
turer’s instructions. The experiments were done at least
three times.
RESULTS
Composition of selenite-induced SGs
To determine whether selenite has the ability to induce
SGs, U2OS cells were treated with various concentrations
of sodium selenite, followed by immunostaining for the
SG markers, TIAR and G3BP. We found that SGs are
assembled in cells exposed to 5mM selenite for 24h
(Supplementary Figure S1A). In most of our experiments,
cells were exposed to 1mM selenite for 2h, as this gave the
most robust results in the shortest time. As shown in
Figure 1A (see Supplementary Figure S1B for unmerged
ﬁgures), co-staining with the P-body marker Hedls/Ge-1
revealed that selenite-induced SGs are often found in close
physical apposition to P-bodies. Although selenite treat-
ment also appeared to increase the percentage of
P-body-positive cells, this difference was not statistically
signiﬁcant (Figure 1A, bar graph). In situ hybridization
using an oligo-dT18 probe demonstrated strong accumu-
lation of poly-A-containing mRNA in selenite-induced
SGs (Figure 1B). Furthermore, emetine and
cycloheximide, drugs that arrest translation elongation
to stabilize polysomes, dissolved SGs in both arsenite-
and selenite-treated cells (20) (Figure 1C). Collectively,
these results reveal that selenite induces bona ﬁde SGs in
which TIAR, G3BP and poly-(A) mRNAs are selectively
Nucleic Acids Research, 2012,Vol.40, No. 16 8101concentrated. We noticed that selenite-induced SGs are
generally smaller (see Supplementary Figure S1C for size
comparison) and found closer to the cell periphery than
arsenite-induced SGs (20). To compare the compositions
of selenite- and arsenite-induced SGs, we ﬁrst stained for
core SG components, namely, translation initiation
factors that constitute the 48S pre-initiation complex
(23). As shown in Figure 2, PABP (poly-A binding
protein), eIF4G, eIF4E and eIF4A are recruited to both
arsenite- and selenite-induced SGs. In contrast, eIF3b, a
protein that is one of the most reliable markers of mam-
malian SGs and is recruited to SGs under various stresses
(18), is selectively excluded from selenite-induced SGs
(Figure 2, bottom panel; compare with Supplementary
Figure S2A). The lack of eIF3b suggests that the
selenite-induced SGs are different from not only
arsenite-induced SGs but also SGs triggered by many
other stimuli in mammalian cells (18). The lack of eIF3b
localization in selenite-induced SGs was also observed
with the human prostate cancer cell line DU145
(Supplementary Figure S2B), conﬁrming that this is not
a phenomenon speciﬁc to U2OS cells. We went on to test
the localization of other established components of
‘canonical’ SGs, as shown in Figure 3. Most of the canon-
ical SG components are efﬁciently recruited to
selenite-induced SGs, including Ago2, FMR1, HuR and
PCBP2 (Figure 3A) (24–27). O-GlcNAc-modiﬁed proteins
were also found in selenite-induced SGs (19). In contrast,
eIF5A (28), eIF3e/Int6 and the small ribosomal protein
Rps14 are only weakly recruited or absent in
selenite-induced SGs (compare with arsenite-induced
SGs shown in Supplementary Figure S2 and Figure 3B).
Among SG components that are not explicitly involved in
RNA metabolism, Rsk2 is recruited to selenite-induced
SGs, possibly through its interaction with TIA-1 (9). In
contrast, RACK1, importin a1/b1 and HDAC6, which are
Figure 1. Induction of bona ﬁde SGs by sodium selenite. (A) (Left panel) Selenite triggers TIAR- and G3BP-positive SGs juxtaposed to P-bodies.
U2OS cells without or with selenite treatment (1mM, 2h) were immunostained for TIAR (red), G3BP (green) and Hedls (blue, cytoplasmic staining).
(Right panel) Percentage of SG- or P-body-positive cells in the presence or absence of selenite, as quantiﬁed from three independent experiments.
Error bars=SD; * and ** denote P-value relative to non-treated cells. (B) Selenite-induced SGs contain poly-A mRNAs. U2OS cells exposed to
arsenite (top) or selenite (bottom) were processed for in situ hybridization to detect poly-A containing mRNA (green), followed by staining of TIAR
(red) and G3BP (blue). (C) Selenite-induced SGs are disassembled by cycloheximide (CHX) and emetine. U2OS cells were treated with arsenite or
selenite for 1hr, followed by co-treatment with CHX or emetine for an additional 1hr. Subsequently, cells were immunostained for TIAR (red),
G3BP (green) and eIF4G (blue). Bars=10mm.
8102 Nucleic Acids Research, 2012,Vol.40, No. 16known components of arsenite-induced SGs, are
excluded from selenite-induced SGs, at least in U2OS
cells (Figure 3C, compare with Supplementary Figure
S2) (3,8,22,29). Thus, selenite-induced SGs are morpho-
logically and compositionally distinct from canonical SGs.
Phophorylation of eIF2a is dispensable for
selenite-induced SG assembly
To examine the effect of selenite on translation, we
measured the rate of de novo protein synthesis using iso-
topically labeled amino acids. As shown in Figure 4A,
Figure 2. Accumulation of major translation initiation factors in selenite-induced SGs. The localization of PABP, eIF4G (top row, red and blue,
respectively), eIF4E (second row, red), eIF4A1 (third row, red) and eIF3b (bottom row, red) was probed by immunostaining of selenite-treated
U2OS cells. Arrows indicate SG localization, whereas arrowheads indicate the lack of enrichment in SGs. Bar=10mm.
Nucleic Acids Research, 2012,Vol.40, No. 16 8103both arsenite and selenite strongly down-regulate global
protein synthesis. In accordance with previous reports
(16,17), selenite induces the phosphorylation of eIF2a,
which probably contributes to translational repression
(Figure 4B). In order to determine whether selenite-
induced SG assembly requires eIF2a phosphorylation,
we used a MEF cell line in which wild-type (WT) eIF2a
is replaced with a non-phosphorylatable mutant
(eIF2aS51A) (30). Although arsenite treatment does not
trigger SG formation in these knock-in (S51A) MEFs,
pateamine A, which induces SGs in a phospho-eIF2a-in-
dependent manner (31), does (Figure 4C). Although
selenite-induced SGs are observed in both WT and S51A
MEFs, the SGs assembled in S51A MEFs are smaller than
those observed in WT MEFs (Figure 4C). Thus, eIF2a
phosphorylation contributes to proper SG assembly by sel-
enite, but it is not indispensable for this process.
Selenite disrupts eIF4F complex formation through
4EBP1, which is at least partially responsible for SG
assembly
Given that eIF2a phosphorylation is not absolutely
required for selenite-induced SG assembly, we compared
Figure 3. Accumulation of various canonical SG components in selenite-induced SGs. The accumulation of canonical SG components, including
(A) RNA-binding proteins (Ago2, FMR1, HuR and PCBP2) and O-GlcNAc-modiﬁed proteins, (B) translation initiation factors other than the ones
tested in Fig. 2 (eIF5A and eIF3e) and the small ribosomal S14 protein (Rps14) and (C) SG constituents that do not possess obvious RNA-binding
activity (Rsk2, RACK1, importin a1/b1 and HDAC6) were probed for SG localization by immunostaining. Arrows indicate localization to SGs,
whereas arrowheads indicate the lack of enrichment. Bar=10mm.
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selenite-treated cells. As shown in Figure 5A, eIF4E is
pulled down by m
7GTP sepharose to a similar extent in
selenite- and arsenite-treated cells, suggesting that the
ability of eIF4E to recognize the 50-cap is not impaired.
However, other components of the eIF4F complex,
including eIF4G, eIF4A and eIF4G/A-interacting
protein eIF3b, are signiﬁcantly reduced in selenite-
treated cells, but not arsenite-treated cells. The association
of 4EBP1 with the cap is selectively increased by selenite,
suggesting that selenite disrupts the eIF4F complex by
enhancing binding of 4EBP1 to eIF4E. We also noticed
a decrease in eIF4G protein levels upon selenite treatment
in the input lysate. Using whole-cell extracts, we con-
ﬁrmed that the total protein level of eIF4G is indeed
down-regulated (Figure 5A, lower panel). This is
unlikely to be due to apoptosis, since apoptosis-induced
proteolysis of eIF4G should produce a 120-kDa cleavage
product that is recognized by the antibody that we are
using (32). We also observed that 4EBP1 in
selenite-treated cells migrates faster than that in control
or arsenite-treated cells. This result suggests that 4EBP1 is
dephosphorylated upon selenite treatment, which typically
indicates inhibition of mTOR activity (1). In fact, levels of
phospho-4EBP1 and ribosomal protein S6 are strongly
reduced by selenite treatment in whole-cell extracts,
further suggesting that selenite inhibits mTOR activity in
these cells (Figure 5A, lower panel).
We next examined the role of 4EBP1 in selenite-induced
SG assembly. Immunoﬂuorescence microscopy revealed
that 4EBP1 is not a component of selenite-induced SGs
(Figure 5B) (4EBP1 antibody was validated for use in im-
munoﬂuorescence in Supplementary Figure S2C, where
4EBP1 signal was strongly reduced by siRNA-mediated
depletion of this protein). However, siRNA-mediated
depletion of 4EBP1 clearly inhibits selenite-induced SG
assembly, but not arsenite-induced SG assembly
(Figure 5C and D). The percentage of SG-positive cells
decreased signiﬁcantly upon selenite treatment, and even
when SGs were assembled, they were far less discrete and
the accumulation of individual granule components was
strongly compromised. Collectively, these results indicate
that, unlike canonical SGs, 4EBP1 protein plays a regula-
tory role in selenite-induced SG assembly, possibly by
feeding the pool of non-translating mRNAs by disrupting
the eIF4F complex.
To examine the physiological role of 4EBP1 in the
selenite-induced stress response, we compared the viability
Figure 4. Selenite potently triggers translational repression and increases phospho-eIF2a level, although eIF2a phosphorylation is not essential for
selenite-induced SG biogenesis. (A) Selenite inhibits translation even more potently than arsenite. De novo protein synthesis rate was measured by
labeling with C
14-lysine and C
14-leucine in untreated, arsenite-treated and selenite-treated cells. Error bars=SD. (B) Increase of phospho-eIF2a
levels by selenite. U2OS cells treated without or with arsenite or selenite (1mM and 2mM) were lysed and subjected to western blotting using
anti-eIF2a, phospho-eIF2a and b-actin antibodies. Densitometric quantiﬁcation of relative eIF2a phosphorylation levels is indicated under each lane
of the phospho-eIF2a panel. (C) Wild-type MEFs (WT) or MEFs bearing S51A mutant eIF2a (S51A) were treated with selenite and immunostained
for HuR (red), TIAR (green), with nuclei revealed with Hoechst (blue). Since S51A MEFs were particularly susceptible to selenite, the drug treatment
condition was modiﬁed to 0.5mM, 2h, to allow both cell lines to remain attached to the coverslip. Bar=10mm.
Nucleic Acids Research, 2012,Vol.40, No. 16 8105of U2OS cells treated with 4EBP1-speciﬁc cells or control
siRNA-transfected cells. Cell viability was assessed by
measuring the amount of intracellular ATP. As shown
in Figure 6, depletion of 4EBP1 signiﬁcantly enhanced
the viability of selenite-treated cells (right panel). In
contrast, 4EBP-1 depletion did not affect the viability of
arsenite-treated cells (Figure 6, left panel). These results
indicate that 4EBP1 contributes to the cytotoxic effect of
selenite, but not arsenite.
ROS production by selenite triggers SG formation
Selenite-induced cytotoxicity is a consequence of ROS
that accumulate during selenite metabolism (13,14,33).
To test the effect of ROS on SG assembly, cells were pre-
treated with MnTMPyP, a cell permeable superoxide
dismutase mimetic, and then exposed to selenite. As
shown in Figure 7A, pretreatment with this ROS scaven-
ger completely suppresses selenite-induced SG assembly,
Figure 5. Involvement of 4EBP1 in selenite-induced eIF4F complex disruption and SG formation. (A) Selenite disrupts eIF4F complex formation
and enhances eIF4E-4EBP1 interaction. (Top) U2OS cells without or with drug treatment (arsenite and selenite) were lysed and subjected to
m
7GTP-sepharose pulldown to isolate cap-associated proteins. Both the input and the precipitate were processed for western blotting and probed
for the presence of eIF4E, eIF4G, eIF4A, eIF3b and 4EBP1. (Bottom) Whole-cell extracts from non-treated or drug-treated cells were prepared by
directly lysing cells with SDS sample buffer, and protein levels of eIF4G, ribosomal protein S6, phospho-S6 and b-actin were examined. (B) 4EBP1
itself is not recruited to selenite SGs. U2OS cells exposed to selenite were immunostained for 4EBP1 (red), TIAR (green) and eIF4E (blue). Arrows
indicate SG localization, whereas the arrowheads indicate the lack of SG accumulation. (C) 4EBP1 depletion by siRNA compromises
selenite-induced SG, but not arsenite-induced SG biogenesis. U2OS cells were transfected with control or 4EBP1-directed siRNA for 72h and
processed for western blotting (top, probed for 4EBP1 and b-actin) or immunostaining (bottom, stained for TIAR, G3BP and treated with Hoechst).
Bar=10mm. (D) The percentage of cells bearing SGs induced by arsenite (left) or selenite (right) without (control) or with 4EBP1 knockdown
(4EBP-kd). siRNA-transfected U2OS cells were processed as above, and the percentage of SG-positive cells was calculated from four independent
experiments. Error bars=SD; P<0.05 by unpaired t-test.
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nomenon. Inhibition of ROS generation by MnTMPyP
signiﬁcantly restored the levels of phosphorylated S6
protein and 4EBP1, whereas selenite-induced phosphoryl-
ation of eIF2a was only weakly attenuated (Figure 7B).
Thus, selenite-induced ROS production is primarily
responsible for the suppression of S6- and 4EBP1 phos-
phorylation, but this is not the case for the induction of
eIF2a phosphorylation.
DISCUSSION
SG assembly is a conserved phenomenon observed in a
wide range of eukaryotic species (2). However, species-
speciﬁc differences in the mechanism of SG assembly,
and the composition of SGs, have been noted. In mam-
malian cells, SGs typically contain eIF4F components
(eIF4E, eIF4G and eIF4A), eIF3 and 40S ribosomal
subunits, and their assembly is strongly dependent upon
individual eIF3 subunits (19). In the budding yeast
Saccharomyces cerevisiae, glucose deprivation induces
mRNA-containing cytoplasmic granules that accumulate
eIF4E, eIF4G and PABP (EGP-bodies), but not eIF3 or
40S ribosomal subunits (34,35). Although their lack of
eIF3 subunits and 40S ribosomal subunits and their
non-reliance on eIF2a phosphorylation for assembly high-
light the differences between yeast EGP-bodies and mam-
malian SGs, some evidence suggests that EGP-bodies may
be functionally analogous to mammalian SGs. Unlike SGs
induced by glucose deprivation, yeasts treated with
sodium azide assemble SGs that more closely resemble
their mammalian counterparts (36), indicating that yeast
cells can assemble more than one class of SGs. Here, using
sodium selenite as a trigger, we have found that mamma-
lian cells can also assemble more than one class of SGs.
The absence or reduced accumulation of ‘later stage’
translation initiation factors, such as eIF3 and eIF5A
and the small ribosomal subunit Rps14 in selenite-induced
SGs is analogous to EGP-bodies, suggests that selenite
stalls messenger RNP remodeling at an earlier step in
translation initiation compared with arsenite. Unlike
EGP-bodies, however, eIF4A is modestly accumulated in
selenite-induced SGs, and O-GlcNAc-modiﬁed proteins,
which are lacking in S. cerevisiae, are found in
Figure 6. Effect of 4EBP1 knockdown on the viability of stressed cells. U2OS cells transfected with control or 4EBP1 siRNA were treated either
with arsenite (at 100mM for 0, 2 and 4h; left panel) or selenite (left, at 1mM for 1h; right, 10mMo r2 0 mM selenite for 24h; right panel).
Subsequently, cell viability was assessed by measuring the amount of intracellular ATP levels. Data represent relative viability expressed as %
control relative to non-treated cells.
Figure 7. Selenite-induced SG biogenesis depends on ROS production.
(A) ROS scavenger MnTMPyP suppresses selenite-induced SGs. U2OS
cells were pre-treated with doubly distilled water or MnTMPyP (10mM,
1h), followed by selenite treatment. Subsequently, cells were ﬁxed and
stained for TIAR (red) and G3BP (green). The nuclei were revealed by
Hoechst staining (blue). Bar=10mm. (B) U2OS cells without treatment
(No treat), with selenite treatment (selenite) or with selenite and
MnTMPyP as above (selenite+MnTMPyP) were lysed and probed
for phospho-eIF2a, phospho-S6, 4EBP1, phospho-4EBP1 and b-actin
levels.
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induced SGs are not an exact counterpart of yeast EGP-
bodies. Moreover, SGs induced in cells exposed to both
selenite and arsenite resemble arsenite-induced SGs with
respect to their large size and the recruitment of eIF3b
(Supplementary Figure S3). In contrast, yeasts exposed
to both glucose deprivation and azide assemble SGs
with the glucose deprivation phenotype (i.e. small size,
lack of eIF3) (36). In addition, the combined stress
resulted in less SG assembly than that observed with
selenite or arsenite alone. Although we cannot fully
explain these phenomena, there may be a competition
between selenite and arsenite regarding a biochemical
event upstream of SG formation.
Another interesting aspect of selenite-induced SGs is
that their biogenesis appears to involve 4EBP, which has
not previously been implicated in SG assembly. Given that
the involvement of 4EBPs in EGP-bodies has never been
tested, it would be of interest to see if Caf20p and Eap1p,
the 4EBP homologues in S. cerevisiae, are involved in
EGP-body biogenesis. We also observed selenite-speciﬁc
loss of phospho-ribosomal S6 protein; considering the
increased eIF4E-4EBP1 interaction and apparent
dephosphorylation of 4EBP1 (Figure 5A), it seems likely
that mTOR activity is down-regulated by selenite, a
possible consequence of selenite-induced ROS
(Figure 7B). This is in line with a recent report, which
monitored mTOR activity through phospho-S6 kinase
levels in the context of autophagy (38). Dephos-
phorylation of neither 4EBP1 nor ribosomal S6 protein
was observed by arsenite (Figure 5A), and the superoxide
dismutase mimetic MnTMPyP failed to inhibit
arsenite-induced SG assembly (Supplementary Figure
S4A), in stark contrast to selenite-induced SG assembly
(Figure 7A). Thus, although arsenite is a known inducer
of oxidative stress, the species of intracellular ROS
generated by arsenite and selenite treatment appear to
be different; both trigger the phosphorylation of eIF2a,
but only the latter diminishes the phosphorylaton of
4EBP1 and S6, possibly by down-regulation of mTOR.
The involvement of mTOR may explain the lack of eIF3
accumulation considering a previous study showing the
mTOR-stimulated association between eIF4G and eIF3
(39). Meanwhile, in line with several previous studies
(40,41), rapamycin did not induce SG assembly in our
system (Supplementary Figure S5), indicating that
selenite may affect mTOR in a manner distinct from
rapamycin. We further attempted to link mTOR to
selenite-induced SG assembly, by comparing selenite-
induced SG assembly in Tsc2 null MEFs (Tsc2 /
 TP53 / ), in which the mTOR activity is constitutively
up-regulated (42), and control MEFs (Tsc2+/+TP53 / )
(Supplementary Figure S4). We found that both SG
assembly and the loss of phospho-S6 as well as dep-
hosphorylation of 4EBP1 are similar in control and
Tsc2-deﬁcient MEFs (Supplementary Figure S4). These
results rule out a direct role for Tsc2 in selenite-induced
SG assembly. Nevertheless, knock-down experiments
clearly implicate 4EBP1, and likely its translational repres-
sion activity, in selenite-induced SG assembly. The reason
why 4EBP1 knockdown did not completely inhibit
SG formation might have been because there are at least
two other known 4EBPs (4EBP2 and 4EBP3) that can
substitute for 4EBP1. In addition, although eIF2a phos-
phorylation is not an absolute requirement, it appears to
contribute to the proper assembly of selenite-induced SGs
(Figure 4C). It may be that phosphorylation of eIF2a
provides a pool of translationally repressed mRNPs,
from which 4EBP-mediated sequestration of eIF4E from
eIF4F complex and subsequent aggregation into discrete
foci preferentially occurs. In addition, there was an
apparent decrease in total eIF4G (Figure 5A), which
may contribute to selenite-triggered translational repres-
sion (Figure 4A). Thus, all these elements may collectively
contribute to selenite-induced inhibition of protein synthe-
sis and SG assembly (Figure 5A).
An important observation regarding selenite-induced
SGs is their lack of accumulation of several canonical
SG components. The lack of eIF3 components, HDAC6
and importin b is particularly striking, since these proteins
are essential for SG assembly by arsenite (8,19). More in-
triguingly, among the four canonical SG components
whose recruitment to SGs promotes cell survival (Rsk2,
RACK1, importin a1 and HDAC6) (4,8,22), three of them
(RACK1, importin a1 and HDAC6) failed to accumulate
in selenite-induced SGs. These results raise the possibility
that selenite-induced SGs may be impaired in their ability
to increase cellular resistance to stress. Consistent with
this hypothesis, cells that are depleted of 4EBP1 and
thus compromised in the ability to assemble
selenite-induced SGs exhibited higher cell viability in
response to selenite stress (Figure 6). It is also possible,
however, that depletion of 4EBP1 promotes cell survival
by a mechanism that is unrelated to SG assembly. This
limits the interpretation of experiments in which knoc-
kdown of multifunctional proteins that are required for
SG assembly is performed.
Taken together, our data suggest that mammalian cells
assemble two classes of SGs with different components,
mechanisms of assembly and physiological roles: Type 1
SGs, induced by arsenite and other types of stress, typic-
ally contain eIF3 subunits and small ribosomal proteins,
are dependent on eIF2a phosphorylation or eIF4A activ-
ity and function to promote cell survival during stress.
Type 2 SGs, induced by selenite, lack eIF3 subunits and
several other critical Type 1 SG components, rely primar-
ily on 4EBP for assembly and inhibit cellular survival
during stress. The possible concurrent involvement of
both eIF2a phosphorylation and mTOR down-regulation
in selenite-induced SG assembly is somewhat reminiscent
of amino acid starvation, where mRNAs bearing 50-
terminal oligopyrimidine tracts (50TOP) are selectively
released from polysomes and sequestered into SGs (43).
It will be of great interest to determine whether SGs
induced by amino acid starvation are Type 2 SGs, and
whether selenite-induced SGs are selectively enriched in
50TOP mRNAs. Our results also imply that selenite
might be a unique anti-cancer drug candidate in that it
efﬁciently represses protein synthesis, which may enable
this compound to target cancer cells reliant on aberrantly
active translation, without invoking cytoprotective func-
tions of canonical SGs.
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